Comparison of gastric and small-bowel transit time between Lubiprostone, and placebo-controlled in healthy volunteers : a double-blind, placebo-controlled study by capsule endoscopy
Phase of Trial: Phase II
Latest Information Update: 17 May 2016
At a glance
- Drugs Lubiprostone (Primary)
- Indications Constipation; Irritable bowel syndrome
- Focus Pharmacodynamics
- 05 Aug 2014 Status changed from recruiting to completed.
- 17 Jan 2014 According to University Hospital Medical Information Network - Japan record, status changed from not yet recruiting to recruiting.
- 21 Aug 2013 New trial record